Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling https://www.biorxiv.org/content/10.1101/2023.03.22.533721v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.